Anti-CD27 agonist antibody varlilumab (varli) with nivolumab (nivo) for colorectal (CRC) and ovarian (OVA) cancer: Phase (Ph) 1/2 clinical trial results Meeting Abstract
| Authors: | Sanborn, R. E.; Pishvaian, M. J.; Callahan, M. K.; Weise, A. M.; Sikic, B. I.; Rahma, O. E.; Cho, D. C.; Rizvi, N. A.; Bitting, R. L.; Starodub, A.; Jimeno, A.; Yellin, M. J.; Rawls, T.; Vitale, L.; Halim, A.; Zhang, H.; Keler, T. |
| Abstract Title: | Anti-CD27 agonist antibody varlilumab (varli) with nivolumab (nivo) for colorectal (CRC) and ovarian (OVA) cancer: Phase (Ph) 1/2 clinical trial results |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 137s |
| Language: | English |
| ACCESSION: | WOS:000442916001376 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.3001 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3001 -- Source: Wos |
